Clinical Trials in Baltimore

Showing 6981-7000 of 17,842 trials

Preventing Anaphylaxis With Acalabrutinib

NCT05038904

Food allergy is a potentially life-threatening condition, and its prevalence continues to increase despite public health efforts. There are currently no known therapies that can reliably prevent food-induced anaphylaxis. This is an open-label study designed to determine the ability acalabrutinib to prevent signs and symptoms of anaphylaxis during an oral food challenge in food-allergic adults.

Food AllergyFood Allergy Peanut

Johns Hopkins University10 participantsStarted Dec 2021

Baltimore, Maryland, United States

COMPLETEDPhase 3< 1 mile

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

NCT04740827

This study will assess the safety, tolerability, and efficacy of Atogepant 60 mg compared with placebo in participants with episodic migraine and who have previously failed 2 to 4 classes of oral prophylactic treatments.

Episodic Migraine

Allergan315 participantsStarted Mar 2021

Colton, California, United States • Encino, California, United States • Los Alamitos, California, United States +111 more locations

Preventing Anaphylaxis With Acalabrutinib

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

Find Trials by Condition in Baltimore

Impact of Fever Prevention in Brain Injured Patients

Treatment Goals in Psoriatic Arthritis

Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen

Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"

Blood Volume Assessment in COVID-19 and Bacterial Sepsis

Development of the Virtual Unified Huntington's Disease Rating Scale

A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer

Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Participants With Glycogen Storage Disease Type III

Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors

MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram

A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer

Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)

Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population

Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598)

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy